特异性-话题@MedSci

#特异性#

563篇内容 | 2714人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1899510, encodeId=873218995102f, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Eur Urol Focus：残疾男性的前列腺特异性抗原检测, objectType=article, longId=215678, objectId=fdad2156e88f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdad2156e88f, replyNumber=0, likeNumber=82, createdTime=2022-07-11, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdad2156e88f, moduleTitle=Eur Urol Focus：残疾男性的前列腺特异性抗原检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdad2156e88f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899488, encodeId=d5231899488a5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nat Commun：综合药物基因组学揭示鼻咽癌亚型特异性治疗反应, objectType=article, longId=211957, objectId=fff921195e17, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fff921195e17, replyNumber=0, likeNumber=63, createdTime=2021-10-13, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fff921195e17, moduleTitle=Nat Commun：综合药物基因组学揭示鼻咽癌亚型特异性治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fff921195e17)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899514, encodeId=e31218995143e, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nature 子刊：白细胞介素2的位点特异性聚乙二醇化通过持续激活调节性T细胞增强免疫抑制, objectType=article, longId=218110, objectId=2db821811090, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2db821811090, replyNumber=0, likeNumber=58, createdTime=2021-10-30, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2db821811090, moduleTitle=Nature 子刊：白细胞介素2的位点特异性聚乙二醇化通过持续激活调节性T细胞增强免疫抑制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2db821811090)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899530, encodeId=51af189953048, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=ARD：宏基因组关联研究揭示了日本系统性红斑狼疮患者肠道微生物群的疾病特异性景观, objectType=article, longId=292935, objectId=0f66292935a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f66292935a5, replyNumber=0, likeNumber=84, createdTime=2022-06-07, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f66292935a5, moduleTitle=ARD：宏基因组关联研究揭示了日本系统性红斑狼疮患者肠道微生物群的疾病特异性景观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f66292935a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899537, encodeId=4963189953e5a, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Lancet Diabetes Endocrinol：回顾15年，糖尿病整体住院率下降，非糖尿病特异性疾病就诊原因有所增加，预防与管理皆应与时俱进！, objectType=article, longId=294607, objectId=cf5629460e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf5629460e71, replyNumber=0, likeNumber=72, createdTime=2022-12-05, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf5629460e71, moduleTitle=Lancet Diabetes Endocrinol：回顾15年，糖尿病整体住院率下降，非糖尿病特异性疾病就诊原因有所增加，预防与管理皆应与时俱进！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf5629460e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899482, encodeId=5f25189948255, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=辉瑞暂停BCMA/CD3双抗elranatamab的临床试验，BCMA/CD3双特异性抗体是全球研发热点, objectType=article, longId=210832, objectId=8fed21083275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fed21083275, replyNumber=0, likeNumber=68, createdTime=2021-06-02, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fed21083275, moduleTitle=辉瑞暂停BCMA/CD3双抗elranatamab的临床试验，BCMA/CD3双特异性抗体是全球研发热点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fed21083275)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899508, encodeId=9ef418995082b, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布, objectType=article, longId=215078, objectId=585a2150e865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=585a2150e865, replyNumber=0, likeNumber=73, createdTime=2021-10-19, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=585a2150e865, moduleTitle=Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=585a2150e865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899507, encodeId=27fe189950e75, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Clin Cancer Res：肿瘤特异性MHC-II可预测乳腺癌从抗PD-1/L1免疫治疗中的获益, objectType=article, longId=215071, objectId=72da2150e145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72da2150e145, replyNumber=0, likeNumber=111, createdTime=2022-05-13, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72da2150e145, moduleTitle=Clin Cancer Res：肿瘤特异性MHC-II可预测乳腺癌从抗PD-1/L1免疫治疗中的获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72da2150e145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899485, encodeId=21761899485a0, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=JAMA：母乳喂养妇女接种COVID-19疫苗后母乳中有特异性抗体, objectType=article, longId=211539, objectId=d56421153976, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d56421153976, replyNumber=0, likeNumber=115, createdTime=2021-09-19, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d56421153976, moduleTitle=JAMA：母乳喂养妇女接种COVID-19疫苗后母乳中有特异性抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d56421153976)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899502, encodeId=b108189950278, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nat Med：局部输注HER2特异性CAR-T细胞治疗复发性/难治性中枢神经系统肿瘤儿童和年轻患者的临床研究, objectType=article, longId=214242, objectId=a2d6214242c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d6214242c7, replyNumber=0, likeNumber=83, createdTime=2021-10-19, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d6214242c7, moduleTitle=Nat Med：局部输注HER2特异性CAR-T细胞治疗复发性/难治性中枢神经系统肿瘤儿童和年轻患者的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d6214242c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899529, encodeId=d5ef189952982, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Front Immunol：DT类毒素对肾小球肾炎患儿免疫活性细胞数量的非特异性调控, objectType=article, longId=291806, objectId=ae8f291806d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae8f291806d5, replyNumber=0, likeNumber=75, createdTime=2022-03-21, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae8f291806d5, moduleTitle=Front Immunol：DT类毒素对肾小球肾炎患儿免疫活性细胞数量的非特异性调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae8f291806d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899476, encodeId=c47418994e663, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=BJU Int：游离/总前列腺特异性抗原（PSA）检测与前列腺癌死亡率之间的关联研究, objectType=article, longId=209870, objectId=fc2e2098e0ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc2e2098e0ff, replyNumber=0, likeNumber=82, createdTime=2021-07-20, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc2e2098e0ff, moduleTitle=BJU Int：游离/总前列腺特异性抗原（PSA）检测与前列腺癌死亡率之间的关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc2e2098e0ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899509, encodeId=58ff189950981, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Lancet：双特异性抗体Teclistamab有望成为复发性/难治性多发性骨髓瘤的新疗法！, objectType=article, longId=215591, objectId=5479215591c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5479215591c2, replyNumber=0, likeNumber=57, createdTime=2021-08-11, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5479215591c2, moduleTitle=Lancet：双特异性抗体Teclistamab有望成为复发性/难治性多发性骨髓瘤的新疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5479215591c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899511, encodeId=5739189951193, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=石药集团与美国Flame Biosciences达成超6亿美元合作协议，推进新型双特异性抗体全球化, objectType=article, longId=215927, objectId=011621592e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=011621592e5c, replyNumber=0, likeNumber=0, createdTime=2021-08-24, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=011621592e5c, moduleTitle=石药集团与美国Flame Biosciences达成超6亿美元合作协议，推进新型双特异性抗体全球化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=011621592e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899473, encodeId=595418994e366, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Eur Urol：肾功能降低容易导致肾细胞癌的癌症特异性死亡？, objectType=article, longId=208911, objectId=7655208911d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7655208911d6, replyNumber=0, likeNumber=44, createdTime=2022-02-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7655208911d6, moduleTitle=Eur Urol：肾功能降低容易导致肾细胞癌的癌症特异性死亡？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7655208911d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899525, encodeId=8c34189952599, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=J Neuroinflammation：COVID-19感染后，脑损伤、内皮损伤和炎症标志物升高并表现出性别方面的特异性改变, objectType=article, longId=221450, objectId=f27a22145003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f27a22145003, replyNumber=0, likeNumber=73, createdTime=2022-06-26, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f27a22145003, moduleTitle=J Neuroinflammation：COVID-19感染后，脑损伤、内皮损伤和炎症标志物升高并表现出性别方面的特异性改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f27a22145003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899450, encodeId=f3ed189945005, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Clin Cancer Res：三特异性T细胞激活蛋白HPN536在表达间皮素的恶性肿瘤中的活性, objectType=article, longId=205939, objectId=eb6620593938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb6620593938, replyNumber=0, likeNumber=87, createdTime=2021-07-17, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb6620593938, moduleTitle=Clin Cancer Res：三特异性T细胞激活蛋白HPN536在表达间皮素的恶性肿瘤中的活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb6620593938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899457, encodeId=91a5189945e94, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, objectType=article, longId=207129, objectId=d13920e12909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d13920e12909, replyNumber=0, likeNumber=70, createdTime=2021-12-21, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d13920e12909, moduleTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d13920e12909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899498, encodeId=d5cf18994984e, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=宜明昂科CD47xHER2双特异性抗体获批临床，适应症为HER2表达的晚期实体瘤, objectType=article, longId=213747, objectId=dec0213e4729, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec0213e4729, replyNumber=0, likeNumber=68, createdTime=2022-02-09, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec0213e4729, moduleTitle=宜明昂科CD47xHER2双特异性抗体获批临床，适应症为HER2表达的晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec0213e4729)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899504, encodeId=9b821899504ac, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=AM J CLIN DERMATOL：使用Dupilumab的特异性皮炎患者无需开展实验室监测, objectType=article, longId=214637, objectId=d42a21463e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d42a21463e4c, replyNumber=0, likeNumber=69, createdTime=2022-03-13, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d42a21463e4c, moduleTitle=AM J CLIN DERMATOL：使用Dupilumab的特异性皮炎患者无需开展实验室监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d42a21463e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特异性

2020-05-29

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Eur Urol Focus：残疾男性的前列腺特异性抗原检测

2022-07-11

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nat Commun：综合药物基因组学揭示鼻咽癌亚型特异性治疗反应

2021-10-13

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nature 子刊：白细胞介素2的位点特异性聚乙二醇化通过持续激活调节性T细胞增强免疫抑制

2021-10-30

jinweidong (审核中...)

前往app查看评论内容

#特异性#

ARD：宏基因组关联研究揭示了日本系统性红斑狼疮患者肠道微生物群的疾病特异性景观

2022-06-07

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Lancet Diabetes Endocrinol：回顾15年，糖尿病整体住院率下降，非糖尿病特异性疾病就诊原因有所增加，预防与管理皆应与时俱进！

2022-12-05

jinweidong (审核中...)

前往app查看评论内容

#特异性#

辉瑞暂停BCMA/CD3双抗elranatamab的临床试验，BCMA/CD3双特异性抗体是全球研发热点

2021-06-02

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布

2021-10-19

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Clin Cancer Res：肿瘤特异性MHC-II可预测乳腺癌从抗PD-1/L1免疫治疗中的获益

2022-05-13

jinweidong (审核中...)

前往app查看评论内容

#特异性#

JAMA：母乳喂养妇女接种COVID-19疫苗后母乳中有特异性抗体

2021-09-19

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nat Med：局部输注HER2特异性CAR-T细胞治疗复发性/难治性中枢神经系统肿瘤儿童和年轻患者的临床研究

2021-10-19

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Front Immunol：DT类毒素对肾小球肾炎患儿免疫活性细胞数量的非特异性调控

2022-03-21

jinweidong (审核中...)

前往app查看评论内容

#特异性#

BJU Int：游离/总前列腺特异性抗原（PSA）检测与前列腺癌死亡率之间的关联研究

2021-07-20

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Lancet：双特异性抗体Teclistamab有望成为复发性/难治性多发性骨髓瘤的新疗法！

2021-08-11

jinweidong (审核中...)

前往app查看评论内容

#特异性#

石药集团与美国Flame Biosciences达成超6亿美元合作协议，推进新型双特异性抗体全球化

2021-08-24

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Eur Urol：肾功能降低容易导致肾细胞癌的癌症特异性死亡？

2022-02-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

J Neuroinflammation：COVID-19感染后，脑损伤、内皮损伤和炎症标志物升高并表现出性别方面的特异性改变

2022-06-26

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Clin Cancer Res：三特异性T细胞激活蛋白HPN536在表达间皮素的恶性肿瘤中的活性

2021-07-17

jinweidong (审核中...)

前往app查看评论内容

#特异性#

长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色

2021-12-21

jinweidong (审核中...)

前往app查看评论内容

#特异性#

宜明昂科CD47xHER2双特异性抗体获批临床，适应症为HER2表达的晚期实体瘤

2022-02-09

jinweidong (审核中...)

前往app查看评论内容

#特异性#

AM J CLIN DERMATOL：使用Dupilumab的特异性皮炎患者无需开展实验室监测

2022-03-13

科室
- - 订阅+
  - 更多科室
工具
服务